Egg beater: Seqirus goes fully cell-based for seasonal flu vaccine
Seqirus’s vaccine offering for the 2019/20 season will be uniquely cell-base, but the firm says traditional egg-based production still plays a role in fighting influenza. Provided each year by the World Health Organization (WHO) Global Influenza Surveillance and Response System (GISRS), candida ...
A 20-acre site in Frederick, Maryland will support the production of Kite’s commercial CAR-T therapies, including Yescarta, from 2021.
Kite, ...
Chromatography and measurement company Waters Corporation experienced a volatile Q1 but its biopharma business remains high, backed by significan ...
Analytics and modeling tools can help deliver more effective and safer therapies to patients says Emerson, fresh from its acquisition of Bioprodu ...
Manufacturing constraints have led to supply issues concerning GlaxoSmithKline’s HPV vaccine, Cervarix, which are set to continue until June.
...
Recent Tweets
-
RT @Dan5tanton: Kite expands manufacturing network: 20-acre site in Frederick, MD will support the production of #Gilead #Kite comm… https://t.co/lkynirnQzj
6 hours ago
-
RT @Dan5tanton: Chromatography and measurement company Waters Corporation experienced a volatile Q1 but its biopharma business rema… https://t.co/WxVZFm9ogU
10 hours ago
-
RT @Dan5tanton: The US Biomedical Advanced Research and Development Authority ( #BARDA ) will use Enesi Pharma’s ImplaVax device an… https://t.co/v6XhAo33hk
1 week ago
-
BREAKING NEWS - more consolidation in gene therapy CMO space https://t.co/DCz8eUuaTQ
1 week ago
Trending
Upstream Processing
Monoclonal Antibodies: Beyond the Platform in Manufacturing
Manufacturing
Antibody Derivatives: Deconstructing MAbs for the Next Wave of Biotherapies
2019
2019 BioProcess International West Event Report
Analytical Upstream Processing
Visible Particulate Matter in Single-Use Bags: From Measurement to Prevention